ARCHIVES

Satraplatin With Prednisone Reduces Risk Of Disease Progression By 33% In Study

This article is from The Cancer Letter archive.

Vol. 30 No. 3 | March 30, 2007

Download PDF Visit The Full Archive

Related Articles

NIH Reconsiders Closing A Meeting Of Advisory Group

January 13, 1995

Bonadonna, Fisher Share %50,000 Bristol-Myers Award

April 23, 1993

NLST Shows 20.3 Percent Mortality Benefit For CT Vs. X-Ray In Lung Cancer Screening

November 5, 2010

NCAB Okays Funding Core Grants For ICC, Hawaii, UC-San Diego

February 15, 1985

Move Starts To Strip Anticancer Drug Regulation From FDA After New Charges It Is Delaying INDs

October 15, 1976

L.I. Center At Stony Brook’s Goal Is Comprehensive Status.

October 27, 2000